Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease

Neuropathology and Applied Neurobiology

Volumn 25, Issue 6, 1999, Pages 435-458

  Merrill, J E ^a   Scolding, N J ^b  

^a CNS Research   (United States)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Demyelination; Lysis; Multiple sclerosis; Necrosis; Oligodendrocytes

Indexed keywords

EXCITOTOXIN; MYELIN;

BRAIN DEGENERATION; CELL DAMAGE; CELL DEATH; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; HUMAN; IMMUNOPATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA;

EID: 0033401226     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00200.x     Document Type: Review

References (248)

1. 1 Agresti C, D'Urso D, Levi G. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage, cell proliferation and differentiation in vitro. Eur J Neurosci 1996; 8: 1106-16
2. 2 Akassoglou K, Probert L, Kontogeorgos G, Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997; 158: 438-45
3. 3 Amor S, Groome N, Linington C et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349-56
4. 4 Antel JP, McCrea E, Ladiwala U, Qin YF, Becher B. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression. J Immunonol 1997; 160: 1606-11
5. 5 Antel JP, Williams K, Blain M, McRea E, McLaurin J. Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Ann Neurol 1994; 35: 341-8
6. 6 Aquino DA, Capello E, Weisstein J et al. Multiple sclerosis: altered expression of 70-and 27-kDa heat shock proteins in lesions and myelin. J Neuropathol Exp Neurol 1997; 56: 664-72
7. 7 Bagasra O, Michaels FH, Zheng YM et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci 1995; 92: 12041-5
8. 8 Banik NL. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit Rev Neurobiol 1992; 6: 257-71
9. 2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem 1985; 45: 581-8.
10. 11 Barres BA, Raff MC. Control of oligodendrocyte numbers in the developing rat optic nerve. Neuron 1994; 12: 935-42
11. 12 Bellander BM, Von Holst H, Fredman P, Svensson M. Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. J Neurosurg 1996; 85: 468-75
12. 13 Bernardo A, Agresti C, Levi G. HIV-gp120 affects the functional activity of oligodendrocytes and their suscptibility to complement. J Neurosci Res 1997; 50: 946-57
13. Bo L, Dawson TM, Wesselingh S et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neuro 1994; 36: 778-86
14. 14 Bonetti B, Pohl J, Gao YL, Raine CS. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997; 159: 5733-41
15. 15 Bonetti B, Raine CS. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neural 1997; 42: 74-84
16. 16 Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci 1995; 92: 7162-6
17. + channels. Neurosci 1994; 63: 135-49
18. 18 Born W, Hall L, Dallas A et al. Recognition of a peptide antigen by heat shock-reactive gamma delta T lymphocytes. Science 1990; 249: 67-9
19. 19 Bornstein M, Appel SH. The application of tissue culture to the study of experimental allergic encephalomyelitis. I. patterns of demyelination. J Neuropathol Exp Neuro 1961; 20: 141-50
20. 20 Bredesen DE. Neurol apoptosis. Ann Neurol 1995; 38: 839-51
21. 21 Bruce AJ, Boling W, Kindy MS et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 1996; 2: 788-94
22. 22 Bruck W, Schmied M, Suchanek G et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994; 35: 65-73
23. 23 Brune B, Messmer UK, Sandau K. The role of nitric oxide in cell injury. Toxicol Lett 1995; 82-83: 233-7
24. 24 Butt AM, Jenkins HG. Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumor necrosis factor. J Neuroimmunol 1994; 51: 27-33
25. 25 Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10
26. 26 Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 1997; 230: 49-52
27. 27 Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995; 37: 424-35
28. 28 Cassaccia-Bonnefil P, Aibel L, Chao MV. Central glial and neruonal populations display differential sensitivity to ceramide-dependent cell death. J Neurosci Res 1996; 43: 382-9
29. 29 Casaccia-Bonnetil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383: 716-9
30. 30 Chakraborty G, Ziemba S, Drivas A, Ledeen RW. Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-α. J Neurosci Res 1997; 50: 466-76
31. 31 Charcot M. Histologie de la sclérose en plaques. Gaz Hôsp 1868; 141: 554-8
32. 32 Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A, Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci 1996; 19: 109-14
33. 33 Chen J, Jin K, Chen M et al. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 1997; 69: 232-45
34. 34 Chew LJ, Fleck MW, Wright P, Scherer SE, Mayer ML, Gallo V. Growth factor-induced transcription of GluR 1 increases functional AMPA receptor density in glial progenitor cells. J Neurosci 1997; 17: 227-40
35. 35 Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA. Nerve growth factor and neurotrophin-3 regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 1996; 16: 6433-42
36. 36 Compston DAS, Morgen BP, Campbell AK et al. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropath App Neurobiol 1989; 15: 307-16
37. 37 Connor JR, Menzies SL. Cellular management of iron in the brain. J Neurol Sci 1995; 134: 33-44
38. 38 Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996; 17: 83-93
39. 39 Conrad C, Andreadis A, Trojanowski JQ et al. Genetic evidence for the involvement of tau in progressive supra-nuclear palsy. Ann Neurol 1997; 41: 277-81
40. 40 Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. Targeted CNS expression of interferon-γ in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996; 7: 354-70
41. 41 Cyong JC, Witkin SS, Rieger B, Barbarese E, Good RA, Day NK. Antibody-independent complement activation by myelin via the classical complement pathway. J Exp Med 1982; 155: 587-98
42. 42 Dal Canto MC, Kim BS, Miller SD, Melvold RW. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis. Methods 1996; 10: 453-61
43. 43 Dal Canto M, Melvold RW, Kim BS, Miller SD. Two models of multiple sclerosis; experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pthological and immunological comparison. Micro Res Tech 1995; 32: 215-29
44. 44 Dawson JW. The histology of disseminated sclerosis. Edinburgh Med J 1916; 17: 229-410
45. 45 De GC, Ruuls SR, Theeuwes JW, Dijkstra CD, Van-der VP. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997; 56: 10-20
46. 46 Dijkstra CD, DeGroot CJA, Huitinga I. The role of macrophages in demyelination. J Neuroimmunol 1992; 40: 183-8
47. 47 Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997; 75: 104-12
48. 48 Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997; 149: 1-11
49. 49 D'Souza S, Alinauskas KA, Antel JP. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 1996; 43: 289-98
50. 50 D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 1995; 15: 7293-300
51. 51 D'Souza SD, Bonetti B, Balasingam V et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996; 184: 2361-70.
52. 52 Duncan ID. Inherited disorders of myelination in the centyral nervous system. In Neuroglia, Eds. H Kettenman, B Ransom. New York: OUP, 1995; 990-1009
53. 53 Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146: 1388-96
54. 54 Ferber IA, Brocke S, Taylor-Edwards C et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996; 156: 5-7
55. 55 Ferrer I, Tortosa A, Macaya A et al. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994; 4: 115-22
56. 56 Fournier T, Riches DWH, Winston BW et al. Divergence in macrophage insulin-like growth factor-1 (IGF-1) synthesis induced by TNF-α and prostaglandin E2. J Immunol 1995; 155: 2123-33
57. 57 Freedman MS, Bitar R, Antel JP. Gamma delta T-cell-human glial cell interactions. II. Relationship between heat shock protein expression and susceptibility to cytolysis. J Neuroimmunol 1997; 74: 143-8
58. 58 Freedman MS, D'Souza S, Antel JP. Gamma delta T-cell-human glial cell interactions. I. In vitro induction of γδ T-cell expansion by human glial cells. J Neuroimmunol 1997; 74: 135-42
59. 59 Freedman MS, Ruijs TCG, Selin LK, Antel JP. Peripheral blood γδT cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol 1991; 30: 794-800
60. 60 Fressinaud C, Vallat J-M, Pouplard-Barthelaix A. Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-like membranes repair in vitro. Glia 1996; 16: 40-50
61. 61 Gallo V, Wright P, McKinnon RD. Expression and regulation of a glutamate receptor subunit by bFGF in oligodendrocyte progenitors. Glia 1994; 10: 149-53
62. + channel block. J Neurosci 1996; 16: 2659-70
63. 63 Gasque P, Singhrao SK, Neal JW et al. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immuno 1998; 160: 3543-54
64. 64 Gay D, Esiri M. Blood-brain harrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain 1991; 114: 557-72
65. 65 Genain CP, Hauser SL. Allergic encephalomyelitis in common marmosets: pathogenesis of a multiple sclerosis-like lesion. Methods 1996; 10: 420-34
66. 66 Genain CP, Abel K, Belmar N et al. Late complications of immune deviation therapy in a nonhuman primate. Science 1996; 274: 2054-7
67. 67 Ghatak NR, Leshner RT, Price AC, Felton WL. Remyelination in the human central nervous system. J Neuropathol Exp Neurol 1989; 48: 507-18
68. 68 Giovannoni G. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis. Mult Scler 1998; 4: 27-30
69. 69 Glozman S, Yavin E. Lipid peroxides are generated by the fetal rat brain after episodes of global ischemia in utero. Neurochem Res 1997; 22: 201-8
70. 70 Goedert M, Spillantini MG. Davies SW. Filamentous nerve cell inclusions in neurodegenerative diseases. Current Biol 1998; 8: 619-32
71. 71 Gold R, Schmied M, Giegerich G et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994; 71: 219-25
72. 72 Griot C, Burge T, Vandevelde M, Peterhans E. Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: a mechanism for bystander demyelination. Acta Neuropathol 1989; 78: 396-403
73. 73 Griot-Wenk M, Griot C, Plister H, Vandevelde M. Antibody-dependent cellular cytotoxicily in antimyelin antibody-induced oligodendrocyte damage in vitro. J Neuroimmunol 1991; 33: 145-55
74. 74 Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Rad Res Comms 1990; 11: 181-93
75. 75 Hanisch U-K, Quirion R. Interleukin-2 as a neuro-regulatory cytokine. Brain Res Rev 1996; 21: 246-84
76. 76 Hartung HP. Immune-mediated demyelination. Ann Neurol 1993; 33: 563-7
77. 77 Hauw J-J, Delaere P, Seilhean D, Cornu P. Morphology of demyelination in the human central nervous system. J Neuroimmunol 1992; 40: 139-52
78. 78 Hayes GM, Woodroofe MN, Cuzner ML. Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci 1987; 80: 25-37
79. 79 Higgins JJ, Litvan I, Pho LT, Li W, Nee LE. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurol 1997; 50: 270-3
80. 80 Hishara S, Shoji S, Okano H, Miura M. ICE/CED 3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 1997; 69: 10-20
81. 81 Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-12
82. 2+ responses in cortical oligodendrocyte progenitors and CG-4 cells. J Neurosci Res 1995; 42: 124-30
83. 83 Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MBA. Primary demyelination in transgenic mice expressing interferon-γ. Nature Med 1997; 3: 1037-41
84. 84 Husain J, Juurlink BHJ. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 1995; 698; 86-94
85. 85 Hutton M, Lendon CL, Rizzu P et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5
86. 86 Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 1994; 174: 157-9
87. 87 James T, Matzelle D, Bartus R, Hogan EL, Banik NL. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res 1998; 51: 218-22
88. 88 Jans H, Heltberg A, Zeeberg I, Kristensen JH, Fog T, Raun NE. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis. Acta Neurol Scand 1984; 69: 34-8
89. 89 Johns TG, Bernard CC. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol 1997; 34: 33-8
90. 2+ changes in individual oligodendrocytes attacked by T-cell perforin. Immunol 1991; 74: 572-7
91. 91 Juurlink BHJ, Husain J. Hyperthermic injury of oligodendrocyte precursor cells: implications for dysmyelination disorders. Brain Res 1994; 641: 353-6
92. 92 Kerlero De Rosbo N, Honegger P, Lassmann H, Matthieu J-M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J Neurochem 1990; 55: 583-7
93. 93 Kierstead HS, Blakemore WF. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1997; 22: 161-70
94. 94 Kierstead HS, Levine JM, Blakemore WF. Response of the oligodendrocyte prgenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998; 22: 161-70
95. 95 Kim YS, Kim SU. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci Res 1991; 29: 100-6
96. + channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 1997; 17: 2669-82
97. 97 Koski CL, Estep AE, SawantMane S, Shin ML, Highbarger L, Hansch GM. Complement regulatory molecules on human myelin and glial cells: Differential expression affects the deposition of activated complement proteins. J Neurochem 1996; 66: 303-12
98. 98 Krakowski M, Owen T. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996; 26: 1641-6
99. 99 Kristensson K, Holmes KV, Duchala CS, Zeller NK, Lazzarini RA, Dubois-Dalcq M. Increased levels of myelin basic protein transcripts gene in virus-induced demyelination. Nature 1986; 322: 544-7
100. 100 Kruger R, Kuhn W, Muller T et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1997; 18: 106-8
101. 2-ceramide. Neurochem Res 1997; 22: 529-34
102. 102 Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neuro 1983; 25: 1-135
103. 103 Lassmann H, Ammerer HP, Kulnig W. Ultrastructural sequence of myelin degradation. Acta Neuropathol 1978; 44: 91-102
104. 104 Lee SC, Raine CS. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J Neuroimmunol 1989; 25: 261-6
105. 105 Li Y, Atashi J. Hayes C, Reap E, Hunt S III. Popko B. Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-γ possible implications for demyelinating disorders. J Neurosci Res 1995; 40: 189-98
106. 106 Liu HN, Almazan G. Glutamate induces c-fos proto-oncogene expression and inhibits proliferation in oligodendrocyte progenitors: receptor characterization. Eur J Neurosci 1995; 7: 2355-63
107. 107 Liu J, Marino MW, Wong G et al. TNF is apotent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med 1997; 3: 1-6
108. 2+ influx in oligodendrocyte progenitors. Eur J Pharmacol 1997; 338:277-87
109. 109 Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993; 259: 689-92
110. 110 Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996; 6: 259-74
111. 111 Ludwin SK. The pathobiology of the oligodendrocyte. J Neuropathol Exp Neurol 1997; 56: 111-24
112. 112 Lumsden CE. Fundamental problems in the pathology of multiple sclerosis and allied demyelinating diseases. Bri Med 1951; 31: 1035-43
113. 113 Lumsden CE. The immunogenesis of the multiple sclerosis plaque. Brain Res 1971; 28: 365-90
114. 114 Ma N, Madigan MC, Chan-Ling T, Hunt NH. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia 1997; 19: 135-51
115. 115 Mackenzie-Graham A, Mitrovic B, Smoll A, Merrill JE. Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev Neurosci 1994; 16: 162-71
116. 116 Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995; 37: 519-30
117. 117 Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J. Myelin degeneration in multiple system atrophy detected by unique antibodies [see comments]. Am J Pathol 1997; 153: 735-44
118. 118 Matute C, Sanchez GM, Martinez ML, Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci 1997; 94: 8830-5
119. 119 Mayer M, Noble M. N-acetyl-1-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci 1994; 91: 7496-500
120. 120 Mayo MW, Wang C-Y. Cogswell PC et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997; 278: 1812-5
121. 121 McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998; 4: 291-7
122. 122 McLaurin J. D'Souza S, Stewart J et al. Effect of tumor necrosis factor α and β on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 1995; 13: 369-81
123. 123 McLarnon JG, Michikawa M, Kim SU. Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes. Glia 1993; 9: 120-6
124. 124 McPhilemy K, Mitchell LS, Griffiths IR et al. Effect of optic nerve transection upon myelin protein gene expression by oligodendrocytes: evidence for axonal influences on gene expression. J Neurocytol 1990; 19: 494-503
125. 125 Menon KK, Piddlesden SJ, Bernard CCA. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induced degradation of myelin basic protein in isolated human myelin. J Neurochem 1997; 69: 214-22
126. 126 Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesion: helpful and harmful. Trends Neurosci 1996; 19: 331-8
127. 127 Merrill JE, Ignarro LJ. Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 15: 2123-41
128. 128 Merrill JE, Murphy SP. Regulation of gene expression in the nervous system by reactive oxygen and nitrogen species. Met Brain Res 1997; 12: 97-112
129. 129 Merrill JE, Murphy SP, Mitrovic B et al. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J Neurosci Res 1997; 48: 372-84
130. 130 Mithen FA, Colburn S, Birchem R. Human tumor necrosis factor does not damage cultures containing rat Schwann cells and sensory neurons. Neurosci Res 1990; 9: 59-63
131. 131 Mitrovic B, Ignarro IJ, Montestruque S, Smoll A, Merrill JE. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neurosci 1994; 61: 575-85
132. 132 Mitrovic B, Ignarro LJ, Vinters HV et al. Nitric oxide induces nccrotic but not apoptotic cell death in oligodendrocytes. Neurosci 1995; 65: 531-9
133. 133 Mitrovic B. Parkinson J. Merrill JE. An in vitro model of oligodenrocyte destruction by nitric oxide and its relevance to multiple sclerosis. Methods 1996; 10: 501-13
134. 134 Morgan BP, Campbell AK, Compston DA. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet 1984; 2: 251-4
135. 135 Morris CS, Esiri MM, Sprinkle TJ, Gregson N. Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases. Neuropath App Neurobiol 1994; 20: 272-81
136. 136 Muir DA, Compston DAS. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res 1996; 44: 1-11
137. 137 Muller LU. Jones JL, Wetsel RA, Gay S, Raine CS, Barnum SR. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J Neurol Sci 1996; 144: 135-41
138. 138 Navikas V, Link H. Review. Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996; 45: 322-33
139. 139 Noble PG, Antel JP, Yong VW. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res 1994; 633: 83-90
140. 140 Norton WT. Do oligodendrocytes divide? Neurochem Res 1996; 21: 495-503
141. 141 Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993; 13: 1441-53
142. 142 Olesxak EL, Katsetos CD, Kuzmak J, Varadhachary A. Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection. J Virol 1997; 71: 3228-35
143. 143 Olsson T. Immunology of multiple sclerosis. Curr Opin Neurol Neurosurg 1992; 5: 195-202
144. 144 Otero GC, Merrill JE. Cytokine receptors on glial cells. Glia 1994; 11: 117-28
145. 145 Otero GC, Merrill JE. Response of human oligodendrocytes to interleukin-2. Brain Behav Immun 1997; 11: 24-38
146. 146 Otero GC, Merrill JE. Molecular cloning of the IL-2Rα, IL-2Rβ, and IL-2Rγ cDNAs from a human oligodendroglioma cell line: presence of IL2 mRNAs in the human central nervous system. Glia 1995; 14: 295-302
147. 147 Ozawa K, Suchanek G, Breitschopf H et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994: 117: 1311-22
148. 148 Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sc 1989; 94: 79-100
149. 149 Papp MI, Lantos PL. Accumulation of tubular structures in oligodcndroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992; 107: 172-82
150. 150 Parkinson JF, Mitrovic B, Merrill JE. The role of nitric oxide in multiple sclerosis. J Mol Med 1997; 75: 174-86
151. 151 Patneau DK, Wright PW, Winters C, Mayor ML, Gallo V. Glial cells of the oligodendrocyte lineage express both kainate-and AMPA-preferring subtypes of glutamate receptor. Neuron 1994; 12: 357-71
152. 152 Pende M, Holtzclaw LA, Curtis JL, Russell JT, Gallo V. Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci 1994; 91: 3215-9
153. 153 Piddlesden SJ, Morgan BP. Killing of rat glial cells by complement; deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol 1993; 48: 169-76
154. 154 Polymeropoulos MH, Lavedan C, Leroy E et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-7
155. 155 Poorkaj P, Bird TD, Wijsman E et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815-25
156. 156 Prabhakar S, D'Souza S, Antel JP, McLaurin J, Schipper HM, Wang E. Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res 1995; 672: 159-69
157. 157 Prineas JW. Pathology of the early lesion in multiple sclerosis. Human Pathol 1975; 6: 531-54
158. 158 Prineas JW. The neuropathology of multiple sclerosis. In Demyelinating Diseases. Eds. PJ Vincken, GW Bruyn, HL Klawans. Amsterdam: Elsevier Science, 1985; 213-57
159. 159 Prineas JW. Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51
160. 160 Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993; 116: 681-93
161. 161 Prineas JW, Graham JS. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1981; 10: 149-58
162. 162 Prineas JW. Kwon EE, Goldenberg PZ. Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503
163. 163 Prineas JW, McDonald WI. Demyelinating diseases. In Greenfield's Neuropathology. Eds. DI Graham, PL Lantos. London: Arnold, 1997; 813-95
164. 164 Prineas JW, Raine CS. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurol 1976; 26: 29-32
165. 165 Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci 1995; 92: 11294-8
166. 166 Qi Y, Dawson G. Effects of hypoxia on oligodendrocyte signal transduction. J Neurochem 1993; 61: 1097-104
167. 167 Raff MC, Barres BA, Burne JF. Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993; 262: 695-700
168. 168 Raine CS. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997; 77: 135-52
169. 169 Raine CS, Bornstein MB. Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. J Neuropatho Exp Neurol 1970; 29: 177-91
170. 170 Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 1981; 45: 534-46
171. 171 Raine CS, Scheinberg LC. On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 1988; 20: 189-201
172. 172 Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exper Neurol 1993; 52: 199-204
173. 173 Raine CS, Wu E, Ivanyi J. Katz D, Brosnan CF. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system? Lab Invest 1996; 75: 109-23
174. 174 Redford EJ. Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain 1995; 118: 869-78
175. 175 Redford EJ. Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997; 120: 2149-57
176. 176 Redford EJ, Smith KJ, Gregson NA et al. A combined inhibitor of matrix metalloproteinase activity and tumor necrosis factor-α processing attenuates experimental autoimmune neuritis. Brain 1997; 120: 1895-905
177. 177 Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 19: 773-6
178. low CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int Immunol 1994; 6: 347-54
179. 179 Rice JE, Vannucci RC, Brierly JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-41
180. 180 RioHortega P. Tercera aportacia al conocimiento morfologico e interpretacion funcional de la oligodendroglia. Mem Real Soc Exp Hist Nat 1928; 14: 5-122
181. 181 Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987; 139: 2593-7
182. 182 Rodriguez M, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol 1994; 18: 3-13
183. 183 Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993; 68: 627-36
184. 184 Ruijs TCG, Freedman MS, Grenier YG, Olivier A, Antel JP. Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes. J Neuroimmunol 1990; 27: 89-97
185. + cytotoxic lymphocytes. J Neuroimmunol 1993; 42: 105-12
186. 186 Ruijs TCG, Olivier A, Antel JP. Serum cytotoxicity to human and rat oligodendrocytes in culture. Brain Res 1990; 517: 99-104
187. 187 Rus HG, Niculescu F, Shin ML. Sublytic complement attack induces cell cycle in oligodendrocytes: S phase induction is dependent on c-jun activation. J Immunol 1996; 156: 4892-900
188. 188 Sanders ME, Koski CL, Robbins D, Shin ML, Frank MM, Joiner KA. Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis. J Immunol 1986; 136: 4456-9
189. 189 Scolding NJ, Compston DA. Growth factors fail to protect rat oligodendrocytes against humoral injury in vitro. Neurosci Lett 1995; 183: 75-8
190. 190 Scolding NJ, Franklin RJM, Stevens S, Heldin CH, Compston DAS, Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998; 121: 2221-8
191. 191 Scolding NJ, Houston WAJ, Morgan BP, Campbell AK, Compston DAS. Reversible injury of cultured rat oligodendrocytes by complement. Immunol 1989; 67: 441-6
192. 192 Scolding NJ, Jones J. Compston DAS, Morgan BP. Oligodendrocyte susceptibility to injury by T-cell perforin. Immunol 1990; 70: 6-10
193. 193 Scolding NJ. Morgan BP, Campbell AK, Compston DA. The role of calcium in rat oligodendrocyte injury and repair. Neurosci Lett 1992; 135: 95-8
194. 194 Scolding NJ, Morgan BP, Campbell AK, Compston DAS. Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage. J Neurol Sci 1990; 97: 155-62
195. 195 Scolding NJ, Morgan BP, Compston DA. The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol 1998; 84: 69-75
196. 196 Scolding NJ, Morgan BP, Houston A, Campbell AK, Linington C, Compston DAS. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. J Neurol Sci 1989; 89: 289-300
197. 197 Scolding NJ, Morgan BP, Houston WAJ, Linington C, Campbell AK, Compston DAS. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989; 339: 620-2
198. 198 Scolding NJ, Rayner PJ. Compston DAS. Early oligodendrocyte progenitors and 'type-2' astrocytes are present in adult human white matter. Neurosci 1999, 89: 1-4
199. 199 Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DAS. A proliferative adult human oligodendrocyte progenitor. Neuroreport 1995; 6: 441-5
200. 200 Scolding NJ, Zajicek JP. Wood N, Compston DAS. The pathogenesis of demyelinating disease. Prog Neurobiol 1994; 43: 143-73
201. + oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci 1991; 88: 6452-6
202. 202 Selmaj K, Brosnan CF, Raine CS. Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: implications for multiple sclerosis. Neurol 1992; 42; 795-800
203. 203 Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-46
204. 204 Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949-54
205. 205 Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes. J Immunol 1991; 147: 1522-9
206. 206 Shirazi Y, Imagawa DK, Shin ML. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes. J Neurochem 1987; 48: 271-8
207. 207 Shirazi Y, McMorris FA, Shin ML. Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte C6 glioma cell hybrids. J Immunol 1989; 142: 4385-91
208. 208 Shirazi Y, Rus HG, Macklin WB, Shin ML. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol 1993; 150: 4581-90
209. 209 Smith KJ, Hall SM. Central demyelination induced in vivo by the calcium ionophore ionomycin. Brain 1994; 117: 1351-6
210. 210 Soliven B, Szuchet S. Signal transduction pathways in oligodendrocytes; role of tumor necrosis factor-α. Int J Dev Neurosci 1995; 13: 351-67
211. 211 Soliven B, Takeda M, Szuchet S. Depolarizing agents and tumor necrosis factor-α modulate protein phosphorylation in oligodendrocytes. J Neurosci Res 1994; 38: 91-100
212. 212 Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998; 8: 387-402
213. 213 Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251: 205-8
214. 214 Spillantini MG, Crowther RA. Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci 1998; 95: 6469-73
215. 215 Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with pre-senile dementia: a disease with abundant neuronal and glial filaments. Prof Natl Acad Sci 1997; 94: 4113-8
216. 216 Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci 1998; 95: 7737-41
217. 217 Spillanlini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-40
218. 218 Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody and complement-mediated demyelination. Ann Neurol 1998; 43: 465-71
219. 219 Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998; 18: 2-25
220. 220 Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 1997; 186: 1233-40
221. 221 Tada M, Diserens A, Desbaillets I, de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase reaction. J Neurosurg 1994; 80: 1063-73
222. 222 Taupin V, Renno T, Bourbonniere L, Peterson AC, Rodriguez M, Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/ microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system. Eur J Immunol 1997; 27: 905-13
223. 223 Thorburne SK, Juurlink BHJ. Low glutahione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 1996; 67: 1014-22
224. 224 Tuohy VK, Yu M, Weinstock Guttman B, Kinkel RP. Diversity and plasticity of self-recognition during the development of multiple sclerosis. J Clin Invest 1997; 99: 1682-90
225. 2+ -dependent protein kinase. J Neurochem 1982; 39: 1397-404
226. 226 Tzeng S-F, Deibler GE, DeVries GH. Exogenous myelin basic protein promotes oligodendrocyte death via increased calcium flux. J Neurosci Res 1995; 42: 768-74
227. 227 Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. Fc receptors on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol 1994; 53: 27-36
228. 228 van NJ Van SA, Bajramovic JJ et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995; 375: 798-801
229. 229 van der Veen RC, Hinton DR, Incardonna F, Hofman FM. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 1997; 77: 1-7
230. 230 Vanguri P, Shin ML. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. J Biol Chem 1988; 263: 7228-34
231. 231 Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995; 1: 732-43
232. 232 Voskuhl RR. Chronic relapsing experimental allergic encephalomyelitis in the SJL mouse: relevant techniques. Methods 1996; 10: 435-9
233. 233 Vrdoljak E, Bill CA, Stephens LC, Van der Kogel AJ. Ang K-K, Tofilon PJ. Radiation-induced apoptosis of oligodendrocytes in vitro. Int J Radiat Biol 1992; 62: 475-80
234. 234 Vyas S, Javoy-Agid F, Herrero M-T et al. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 1997; 69: 223-31
235. 235 Wang C, Pralong WE, Schulz MF et al. Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol 1996; 135: 1565-81
236. 236 Willenborg DO, Fordham S, Bernard CCA, Cowden WB, Ramshaw IA. IFN-γ plays a critical down regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996; 157: 3223-7
237. 237 Wilt SG, Milward E, Zhou JM et al. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 1995; 37: 381-94
238. 238 Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 1998; 18: 50-60
239. 239 Wood A, Wing MG, Benham CD, Compston DAS. Specific induction of intracellular calcium oscillations by complement membrane attack on oligodendroglia. J Neurosci 1993; 13: 3319-32
240. 240 Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986; 74: 135-52
241. 241 Yonezawa M, Back SA, Gan X, Rosenberg PA, Volpe JJ. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and a diffusible glial factor. J Neurochem 1996; 67: 566-73
242. 242 Yoon SO, Casaccia BP, Carter B, Chao MV. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 1998; 18: 3273-81
243. 243 Yoshioka A, Bacskai B, Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J Neurosci Res 1996; 46: 427-37
244. 244 Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 1995; 64: 2442-8
245. 245 Yoshioka A, Shimizu Y, Hirose G, Kitasato H, Pleasure D. Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. J Neurochem 1998; 70: 2416-23
246. 246 Zajicek JP, Wing M, Scolding NJ, Compston DAS. Interactions between oligodendrocytes and microglia. Brain 1992; 115: 1611-31
247. 247 Zajicek J, Wing M, Skepper J, Compston A. Human oligodendrocytes are not sensitive to complement: a study of CD59 expression in the human central nervous system. Lab Invest 1995; 73: 128-38
248. 248 Zurbriggen A, Vendevelde M, Dumas M, Griot C, Bollo E. Oligodendroglial pathology in canine distemper virus infection in vitro. Acta Neuropathol 1987; 74: 366-73